Related Experiment Video
Updated: May 18, 2026
Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implications
Michael A Postow1, Mark E Robson
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. robsonm@mskcc.org.
Abstract:
The discovery of underlying molecular genetic abnormalities in gastrointestinal stromal tumors (GISTs) such as activating mutations in the tyrosine kinase genes, KIT and platelet derived growth factor receptor-alpha (PDGFRA), has led to remarkable clinical advances in treatment. Small molecule inhibitors such as imatinib and sunitinib are known to inhibit the aberrantly activated KIT and PDGFRA receptor signaling and can lead to excellent clinical outcomes for patients with GIST. Though the majority of GISTs appear to arise sporadically, a number of families with high frequencies of GISTs have been reported and germline mutations have been identified. This review will highlight the various inherited mutations associated with familial GIST syndromes and describe how an improved understanding of these genetic syndromes has important clinical implications for future understanding of this heterogeneous disease.
Insights
Familial gastrointestinal stromal tumors (GISTs) are linked to inherited mutations in KIT and PDGFRA genes. Understanding these genetic syndromes improves GIST treatment and diagnosis.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Gastrointestinal stromal tumors (GISTs) are driven by activating mutations in KIT and PDGFRA tyrosine kinase genes.
- Targeted therapies like imatinib and sunitinib have significantly improved GIST patient outcomes by inhibiting these aberrant signaling pathways.
Purpose of the Study:
- To review inherited mutations associated with familial GIST syndromes.
- To discuss the clinical implications of understanding these genetic GIST syndromes.
Main Methods:
- Literature review of studies on familial GIST syndromes.
- Analysis of genetic mutations in KIT and PDGFRA genes in hereditary GIST cases.
Main Results:
- Identified various inherited mutations in KIT and PDGFRA genes responsible for familial GIST.
- Highlighted the genetic basis of hereditary GIST syndromes.
Conclusions:
- Germline mutations in KIT and PDGFRA are key in familial GIST development.
- Improved understanding of GIST genetic syndromes is crucial for personalized medicine and future research in this heterogeneous disease.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...